Current Knowledge, Barriers to Implementation, and Future Directions in Palliative Care for End-Stage Liver Disease.
Liver Transpl
; 25(5): 787-796, 2019 05.
Article
em En
| MEDLINE
| ID: mdl-30758901
End-stage liver disease (ESLD) is associated with a high degree of morbidity and mortality as well as symptom burden. Despite this, the rate of consultation with palliative care (PC) providers remains low, and invasive procedures near the end of life are commonplace. Studies show that involvement of PC providers improves patient satisfaction, and evidence from other chronic diseases demonstrates reduced costs of care and potentially increased survival. Better integration of PC is imperative but hindered by patient and provider misconceptions about its role in the care of patients with ESLD, specifically among candidates for liver transplantation. Additionally, reimbursement barriers and lack of provider knowledge may contribute to PC underutilization. In this review, we discuss the benefits of PC in ESLD, the variability of its delivery, and key stakeholders' perceptions about its use. Additionally, we identify barriers to more widespread PC adoption and highlight areas for future research.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cuidados Paliativos
/
Efeitos Psicossociais da Doença
/
Doença Hepática Terminal
/
Implementação de Plano de Saúde
Tipo de estudo:
Diagnostic_studies
/
Prognostic_studies
/
Sysrev_observational_studies
Aspecto:
Implementation_research
/
Patient_preference
Limite:
Humans
Idioma:
En
Revista:
Liver Transpl
Assunto da revista:
GASTROENTEROLOGIA
/
TRANSPLANTE
Ano de publicação:
2019
Tipo de documento:
Article
País de publicação:
Estados Unidos